These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 18240386)

  • 1. A highly efficient route to enantiomerically pure l-N-Bz-Pmp(t-Bu)2-OH and incorporation into a peptide-based protein tyrosine phosphatase inhibitor.
    Hubbard CE; Barrios AM
    Bioorg Med Chem Lett; 2008 Jan; 18(2):679-81. PubMed ID: 18240386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Why is phosphonodifluoromethyl phenylalanine a more potent inhibitory moiety than phosphonomethyl phenylalanine toward protein-tyrosine phosphatases?
    Chen L; Wu L; Otaka A; Smyth MS; Roller PP; Burke TR; den Hertog J; Zhang ZY
    Biochem Biophys Res Commun; 1995 Nov; 216(3):976-84. PubMed ID: 7488220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 4'-O-[2-(2-fluoromalonyl)]-L-tyrosine: a phosphotyrosyl mimic for the preparation of signal transduction inhibitory peptides.
    Burke TR; Ye B; Akamatsu M; Ford H; Yan X; Kole HK; Wolf G; Shoelson SE; Roller PP
    J Med Chem; 1996 Mar; 39(5):1021-7. PubMed ID: 8676336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A protected l-bromophosphonomethylphenylalanine amino acid derivative (BrPmp) for synthesis of irreversible protein tyrosine phosphatase inhibitors.
    Tulsi NS; Downey AM; Cairo CW
    Bioorg Med Chem; 2010 Dec; 18(24):8679-86. PubMed ID: 21055952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. L-O-(2-malonyl)tyrosine: a new phosphotyrosyl mimetic for the preparation of Src homology 2 domain inhibitory peptides.
    Ye B; Akamatsu M; Shoelson SE; Wolf G; Giorgetti-Peraldi S; Yan X; Roller PP; Burke TR
    J Med Chem; 1995 Oct; 38(21):4270-5. PubMed ID: 7473554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonhydrolyzable phosphotyrosyl mimetics for the preparation of phosphatase-resistant SH2 domain inhibitors.
    Burke TR; Smyth MS; Otaka A; Nomizu M; Roller PP; Wolf G; Case R; Shoelson SE
    Biochemistry; 1994 May; 33(21):6490-4. PubMed ID: 7515682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent inhibition of insulin receptor dephosphorylation by a hexamer peptide containing the phosphotyrosyl mimetic F2Pmp.
    Burke TR; Kole HK; Roller PP
    Biochem Biophys Res Commun; 1994 Oct; 204(1):129-34. PubMed ID: 7524496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent inhibition of protein-tyrosine phosphatase by phosphotyrosine-mimic containing cyclic peptides.
    Akamatsu M; Roller PP; Chen L; Zhang ZY; Ye B; Burke TR
    Bioorg Med Chem; 1997 Jan; 5(1):157-63. PubMed ID: 9043667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein-tyrosine phosphatase inhibition by a peptide containing the phosphotyrosyl mimetic, L-O-malonyltyrosine.
    Kole HK; Akamatsu M; Ye B; Yan X; Barford D; Roller PP; Burke TR
    Biochem Biophys Res Commun; 1995 Apr; 209(3):817-22. PubMed ID: 7537500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concise and enantioselective synthesis of Fmoc-Pmp(But)2-OH and design of potent Pmp-containing Grb2-SH2 domain antagonists.
    Li P; Zhang M; Peach ML; Liu H; Yang D; Roller PP
    Org Lett; 2003 Aug; 5(17):3095-8. PubMed ID: 12916990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A two stage click-based library of protein tyrosine phosphatase inhibitors.
    Xie J; Seto CT
    Bioorg Med Chem; 2007 Jan; 15(1):458-73. PubMed ID: 17046267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The difluoromethylenesulfonic acid group as a monoanionic phosphate surrogate for obtaining PTP1B inhibitors.
    Leung C; Grzyb J; Lee J; Meyer N; Hum G; Jia C; Liu S; Taylor SD
    Bioorg Med Chem; 2002 Jul; 10(7):2309-23. PubMed ID: 11983529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptidomimetic competitive inhibitors of protein tyrosine phosphatases.
    Shen K; Qi L; Stiff L
    Curr Pharm Des; 2010; 16(28):3101-17. PubMed ID: 20687872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Difluro(phosphono)methyl]phenylalanine-containing peptide inhibitors of protein tyrosine phosphatases.
    Desmarais S; Friesen RW; Zamboni R; Ramachandran C
    Biochem J; 1999 Jan; 337 ( Pt 2)(Pt 2):219-23. PubMed ID: 9882618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substrate selection influences molecular recognition in a screen for lymphoid tyrosine phosphatase inhibitors.
    Kulkarni RA; Vellore NA; Bliss MR; Stanford SM; Falk MD; Bottini N; Baron R; Barrios AM
    Chembiochem; 2013 Sep; 14(13):1640-7. PubMed ID: 23956195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small molecule peptidomimetics containing a novel phosphotyrosine bioisostere inhibit protein tyrosine phosphatase 1B and augment insulin action.
    Bleasdale JE; Ogg D; Palazuk BJ; Jacob CS; Swanson ML; Wang XY; Thompson DP; Conradi RA; Mathews WR; Laborde AL; Stuchly CW; Heijbel A; Bergdahl K; Bannow CA; Smith CW; Svensson C; Liljebris C; Schostarez HJ; May PD; Stevens FC; Larsen SD
    Biochemistry; 2001 May; 40(19):5642-54. PubMed ID: 11341829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide probes containing a non-hydrolyzable phosphotyrosine-mimetic residue for enrichment of protein tyrosine phosphatases.
    Tsumagari K; Niinae T; Otaka A; Ishihama Y
    Proteomics; 2022 Feb; 22(4):e2100144. PubMed ID: 34714599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptidic alpha-ketocarboxylic acids and sulfonamides as inhibitors of protein tyrosine phosphatases.
    Chen YT; Xie J; Seto CT
    J Org Chem; 2003 May; 68(10):4123-5. PubMed ID: 12737607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phospho-Azatyrosine, a less effective protein-tyrosine phosphatase substrate than phosphotyrosine.
    Burke TR; Yao ZJ; Ye B; Miyoshi K; Otaka A; Wu L; Zhang ZY
    Bioorg Med Chem Lett; 2001 May; 11(10):1265-8. PubMed ID: 11392533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein tyrosine kinase inhibitors block the stimulatory actions of phosphotyrosine phosphatase inhibitors to increase cell proliferation, alkaline phosphatase activity, and collagen synthesis in normal human bone cells.
    Yoon HK; Baylink DJ; Lau KH
    Am J Nephrol; 2000; 20(2):153-62. PubMed ID: 10773618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.